10-Q: TOMI Environmental Solutions Reports First Quarter 2024 Results, Revenue Declines Amidst Strong Sales Pipeline Growth

TOMI Environmental Solutions experienced a revenue decrease in the first quarter of 2024, despite a growing sales pipeline and increased demand for their SteraMist technology.

Summary

• TOMI Environmental Solutions reported a net loss of $1.31 million for the first quarter of 2024, compared to a net loss of $1.19 million in the same period of 2023.
• Revenue for the quarter was $1.11 million, a decrease of 30% from $1.58 million in the first quarter of 2023, primarily due to the timing of customer orders and revenue recognition.
• The company's sales backlog at the end of the quarter was approximately $900,000, expected to be recognized as revenue in the second and third quarters of 2024.
• Operating expenses decreased to $1.90 million from $2.13 million year-over-year, mainly due to lower selling expenses and equity compensation.
• The company's cash used in operations was $1.18 million for the quarter.
• TOMI's total assets were $11.96 million, and total liabilities were $4.88 million as of March 31, 2024.
• The company's working capital was $6.57 million as of March 31, 2024.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While there are positive developments such as a growing sales pipeline, new contracts, and product innovations, the significant revenue decline and net loss raise concerns. The company's belief that its stock price is depressed and the mention of aggressive short selling tactics also add a layer of uncertainty. The sentiment is neutral to slightly negative.

Positives

• The company's sales pipeline is growing both domestically and internationally.
• There is increased demand for the company's CES systems and iHP corporate service.
• TOMI is exploring new markets, including the biofuel and data center industries.
• The company is actively developing new products, including the SteraMist Integration System (SIS) and the SteraMist Hybrid.
• TOMI has a strong intellectual property portfolio with over 25 patents worldwide.
• The company is expanding its trademark protection into new markets like India.

Negatives

• The company experienced a 30% decrease in revenue compared to the same quarter last year.
• The company reported a net loss of $1.31 million for the quarter.
• Cash used in operations was $1.18 million for the quarter.
• The company's domestic revenue decreased by $466,000 compared to the same period last year.

Risks

• The company's revenues can fluctuate due to various factors, including the length of the sales cycle and the timing of orders.
• The company could incur operating losses and increased costs related to product development, sales, and compliance.
• The company's stock price is depressed and may not reflect the actual valuation of the company.
• The company believes that certain investors are engaging in aggressive short selling tactics that are driving down the stock price.
• The company may require additional liquidity to continue operations over the next 12 months.

Future Outlook

The company anticipates growth in top-line revenues for the remainder of 2024 and into 2025, driven by a growing sales pipeline and new product introductions. TOMI expects that the cash generated from core operations will be sufficient to cover future capital expenditures and near-term debt obligations. The company may consider financing transactions to fund operations if opportunities arise.

Management Comments

• Management believes that the company possesses the best technologies in the world in the disinfection and decontamination space.
• Management believes that analyzing the sales order and backlog metrics are useful in measuring the company's overall sales and business development performance.
• Management believes that the current and historical trading prices of the company's common stock is depressed and does not reflect the actual valuation of the company.
• Management believes that certain investors are engaging in aggressive short selling tactics that are driving down the stock price.

Industry Context

The report highlights TOMI's position in the disinfection and decontamination market, particularly in the life sciences, healthcare, and food safety sectors. The company is adapting to the evolving needs of these industries, including the increasing demand for automated solutions and the need for environmentally friendly alternatives to traditional methods. The report also notes the potential impact of regulatory changes, such as the EPA's new restrictions on ethylene oxide emissions, which could create opportunities for TOMI's technology.

Comparison to Industry Standards

• The report does not provide specific comparisons to industry standards in terms of financial performance, but it does highlight the company's unique technology and its ability to achieve a 6-log kill rate of pathogens, which is a key differentiator in the disinfection market.
• The company's focus on environmentally friendly solutions aligns with the growing trend towards sustainability in various industries.
• The company's expansion into new markets, such as biofuel and data centers, demonstrates its adaptability and potential for growth.
• The company's development of custom engineered systems (CES) and integration systems (SIS) positions it to compete with other companies offering modular cleanroom solutions.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the revenue decline and net loss, as well as the company's belief that its stock price is depressed.
• Employees may be affected by changes in headcount and compensation.
• Customers may benefit from the company's new products and services.
• Suppliers may be affected by changes in the company's purchasing patterns.
• Creditors may be affected by the company's debt obligations and liquidity position.

Next Steps

• The company will continue to expand its sales pipeline and convert its backlog into revenue.
• The company will continue to develop and launch new products.
• The company will continue to pursue new markets and partnerships.
• The company will continue to expand its marketing, advertising, and educational campaigns.
• The company will continue to provide training, maintenance, and servicing of capital equipment worldwide.
• The company will continue to offer protocol development and implementation services for SteraMist iHP.

Key Dates

Keywords

SteraMist, Binary Ionization Technology, iHP, decontamination, disinfection, life sciences, healthcare, food safety, environmental solutions, ethylene oxide, cleanroom, patents, sales pipeline, service revenue